Form 4: Ibotta Officer Granted 88,663 Restricted Stock Units
Insider Trading Report
Ibotta's Chief Business Development Officer, Amir El Tabib, was granted 88,663 Restricted Stock Units, vesting quarterly starting March 2, 2026.
Summary
- Amir El Tabib, Chief Business Development Officer of Ibotta, Inc. (IBTA), was granted 88,663 Restricted Stock Units (RSUs) on January 8, 2026.
- Each RSU represents a contingent right to receive one share of Ibotta's Class A Common Stock upon settlement.
- The RSUs will vest in installments: 1/16th on March 2, 2026, and 1/16th on each subsequent Quarterly Vesting Date (defined as the first trading day on or after March 1, June 1, September 1, and December 1), contingent on continuous service.
- Following this transaction, El Tabib beneficially owns 211,967 shares, which include these RSUs.
Sentiment
Score: 7
Explanation: The RSU grant is a positive for executive retention and alignment of interests, which is generally viewed favorably. It's a standard compensation event rather than a significant operational or financial announcement.
Positives
- The grant of Restricted Stock Units (RSUs) to a key executive aligns management's interests with long-term shareholder value.
- The vesting schedule incentivizes continuous service and performance from the Chief Business Development Officer.
Future Outlook
The RSU grant establishes a future vesting schedule, with the first tranche vesting on March 2, 2026, and subsequent tranches vesting quarterly thereafter, contingent on the executive's continued service.
Industry Context
Executive equity grants, particularly RSUs, are a standard component of compensation packages in the technology and growth sectors, aiming to retain key talent and align their financial incentives with company performance and shareholder returns.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Amir El Tabib granted a Limited Power of Attorney to David Shapiro and Matt Puckett for the purpose of executing and filing SEC forms (144, ID, 3, 4, 5) related to his securities ownership, acquisition, or disposition. | 12/04/2025 | Streamlines the process for the executive to comply with SEC reporting requirements for insider transactions. |
Stakeholder Impact
- Shareholders: Potential positive impact through increased alignment of executive incentives with long-term company performance.
- Employees: May signal stability in executive leadership and a commitment to retaining key talent.
Next Steps
- Continued service by Amir El Tabib to meet vesting conditions.
- Vesting of 1/16th of the RSUs on March 2, 2026.
- Subsequent quarterly vesting of RSUs on designated Quarterly Vesting Dates.
Key Dates
| Date | Description |
|---|---|
| 12/04/2025 | Date of execution of Limited Power of Attorney by Amir El Tabib. |
| 01/08/2026 | Date of RSU grant transaction for Amir El Tabib. |
| 01/12/2026 | Date of filing of the Form 4. |
| 03/02/2026 | First vesting date for 1/16th of the granted RSUs. |
| 03/01 | Quarterly Vesting Date (first trading day on or after March 1). |
| 06/01 | Quarterly Vesting Date (first trading day on or after June 1). |
| 09/01 | Quarterly Vesting Date (first trading day on or after September 1). |
| 12/01 | Quarterly Vesting Date (first trading day on or after December 1). |
Recommendation
holdThis Form 4 reports a routine grant of Restricted Stock Units (RSUs) to a key executive as part of their compensation package. While it aligns executive incentives with shareholder interests, it does not present new material information that would warrant a change in investment recommendation. The transaction is an expected part of ongoing corporate governance and compensation practices.
Keywords
Ibotta, IBTA, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4, Amir El Tabib, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.